Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TELATELA Bio, Inc.

Nasdaq · CIK 0001561921
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts281

Identity from submissions API

NameTELA Bio, Inc.
CIK0001561921
TickersTELA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN455320061
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone484-320-2930
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1 GREAT VALLEY PARKWAY, SUITE 24
MALVERN
PA
19355
PA
Mailing address
1 GREAT VALLEY PARKWAY, SUITE 24
MALVERN
PA
19355
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

552 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003578 333-299966 261572177 33 1752
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001440771-26-000032 005-91207 261555721 34 17639
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127214 005-91207 261553895 34 11556
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-460552 005-91207 261552112 34 16869
2026-11-10 S-3 S-3 0001104659-26-125285 333-299966 261541222 33 1181807 1 1
2026-11-10 10-Q 10-Q 0001104659-26-125190 001-39130 261540561 34 7215015 1 1
2026-11-10 8-K FORM 8-K 2.02,9.01 0001104659-26-125147 001-39130 261540208 34 349691 1 1
2026-10-19 4 xslF345X06/form4-10192026_091058.xml 0001456817-26-000017 4979
2026-10-19 4 xslF345X06/form4-10192026_091008.xml 0001685640-26-000006 4999
2026-10-08 8-K FORM 8-K 5.07 0001104659-26-114695 001-39130 261449968 34 193412 1 1
2026-10-06 8-K FORM 8-K 8.01 0001104659-26-114042 001-39130 261444032 34 186689 1 1
2026-10-05 8-K FORM 8-K 8.01,9.01 0001104659-26-113506 001-39130 261438823 34 210845 1 1
2026-09-29 8-K FORM 8-K 1.01 0001104659-26-111920 001-39130 261423692 34 188912 1 1
2026-09-18 4 xslF345X06/form4-09182026_040903.xml 0001456817-26-000015 7227
2026-09-18 8-K FORM 8-K 3.01 0001104659-26-108935 001-39130 261390864 34 193714 1 1
2026-09-16 4 xslF345X06/form4-09162026_100937.xml 0001456817-26-000013 7228
2026-09-14 DEF 14A DEF 14A 0001104659-26-107491 001-39130 261377366 34 1112398
2026-09-04 PRE 14A PRE 14A 0001104659-26-105492 001-39130 261362094 34 1113676
2026-08-31 8-K FORM 8-K 2.05,5.02,7.01,9.01 0001104659-26-103548 001-39130 261342488 34 237114 1 1
2026-08-19 4 xslF345X06/form4-08192026_040807.xml 0001481485-26-000008 5260
2026-08-17 4 xslF345X06/form4-08172026_080836.xml 0001481485-26-000006 5259
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097280 005-91207 261282931 34 11281
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-096813 005-91207 261278992 34 8291
2026-08-13 8-K/A FORM 8-K/A 5.02 0001104659-26-095892 001-39130 261273166 34 192705 1 1
2026-08-11 S-8 S-8 0001104659-26-094126 333-298237 261264221 33 212424 1 1
2026-08-11 10-Q 10-Q 0001104659-26-094039 001-39130 261263149 34 6424460 1 1
2026-08-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-093857 005-91207 261261277 34 8246
2026-08-10 8-K FORM 8-K 2.02,9.01 0001104659-26-093371 001-39130 261258541 34 294517 1 1
2026-08-05 4 xslF345X06/form4-08052026_080838.xml 0001481485-26-000004 9525
2026-08-05 3 xslF345X06/form3-08052026_080800.xml 0001481485-26-000003 9054
2026-08-04 S-8 FORM S-8 0001104659-26-090468 333-297967 261239909 33 247499 1 1
2026-08-04 8-K FORM 8-K 5.02 0001104659-26-090056 001-39130 261235421 34 204243 1 1
2026-07-17 4 xslF345X06/form4-07172026_050703.xml 0001685640-26-000003 5000
2026-07-17 4 xslF345X06/form4-07172026_050701.xml 0001456817-26-000011 4978
2026-06-11 4 xslF345X06/form4-06112026_100617.xml 0002089250-26-000001 7622
2026-06-11 4 xslF345X06/form4-06112026_100651.xml 0001456817-26-000009 11719
2026-06-11 3 xslF345X06/form3-06112026_100612.xml 0001456817-26-000008 8382
2026-06-11 4 xslF345X06/form4-06112026_100629.xml 0001685640-26-000001 7636
2026-06-11 3 xslF345X06/form3-06112026_100611.xml 0001222362-26-000011 8379
2026-06-11 4 xslF345X06/form4-06112026_100640.xml 0001222362-26-000010 11720
2026-06-11 3 xslF345X06/form3-06112026_100652.xml 0001166776-26-000003 8331
2026-06-11 4 xslF345X06/form4-06112026_100622.xml 0001166776-26-000002 11672
2026-06-11 3 xslF345X06/form3-06112026_100607.xml 0001198330-26-000008 8317
2026-06-11 4 xslF345X06/form4-06112026_100610.xml 0001198330-26-000007 11662
2026-06-11 8-K FORM 8-K 5.02,5.07,9.01 0001104659-26-072931 001-39130 261083043 34 224583 1 1
2026-06-09 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-264406 005-91207 261077452 34 132682
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000935836-26-000257 005-91207 26985095 34 6612
2026-05-13 10-Q 10-Q 0001104659-26-060234 001-39130 26973256 34 5577075 1 1
2026-05-12 8-K FORM 8-K 2.02,7.01,9.01 0001104659-26-059393 001-39130 26968608 34 5100155 1 1
2026-04-30 ARS ARS 0001104659-26-053147 001-39130 26927031 34 2514702
2026-04-30 DEFA14A DEFA14A 0001104659-26-053141 001-39130 26926993 34 701021
2026-04-30 DEF 14A DEF 14A 0001104659-26-053117 001-39130 26926900 34 4956071 1 1
2026-04-30 8-K FORM 8-K 2.02,5.02 0001104659-26-053102 001-39130 26926790 34 208623 1 1
2026-03-25 S-8 FORM S-8 0001104659-26-034540 333-294600 26792839 33 246751 1 1
2026-03-25 10-K 10-K 0001104659-26-034507 001-39130 26792431 34 12031015 1 1
2026-03-24 8-K FORM 8-K 2.02,7.01,9.01 0001104659-26-033839 001-39130 26786190 34 4989310 1 1
2026-03-20 8-K FORM 8-K 3.01 0001104659-26-032697 001-39130 26778245 34 190919 1 1
2026-03-11 3 xslF345X02/form3-03112026_080357.xml 0002117151-26-000002 10392
2026-02-24 4 xslF345X05/form4-02252026_010251.xml 0001195881-26-000002 12015
2026-02-24 4 xslF345X05/form4-02242026_080217.xml 0001984584-26-000002 10685
2026-02-24 4 xslF345X05/form4-02242026_080215.xml 0001899089-26-000002 10487
2026-02-24 4 xslF345X05/form4-02242026_080213.xml 0001591474-26-000002 10688
2026-02-24 4 xslF345X05/form4-02242026_080211.xml 0002012926-26-000004 7268
2026-02-24 4 xslF345X05/form4-02242026_080209.xml 0001899973-26-000002 9548
2025-12-23 424B3 424B3 0001104659-25-124007 333-292090 251595311 33 218547
2025-12-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003847 333-292090 251584839 33 1752
2025-12-16 CORRESP filename1.htm 0001104659-25-121648 7156
2025-12-12 S-3 S-3 0001104659-25-120478 333-292090 251566556 33 478459 1 1
2025-11-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000359 005-91207 251491368 34 22227
2025-11-17 4 xslF345X05/form4.xml 0000908834-25-000358 11777
2025-11-14 8-K FORM 8-K 1.01,1.02,2.03,3.02,9.01 0001104659-25-112653 001-39130 251487424 34 2590650 1 1
2025-11-14 424B5 424B5 0001104659-25-112577 333-275511 251486719 33 700868
2025-11-14 10-Q 10-Q 0001104659-25-112476 001-39130 251485945 34 6482060 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000689 005-91207 251484415 34 6507
2025-11-13 424B5 424B5 0001104659-25-111400 333-275511 251479226 33 702092
2025-11-13 8-K FORM 8-K 2.02,7.01,9.01 0001104659-25-111285 001-39130 251478481 34 6235215 1 1
2025-11-03 4 xslF345X05/form4-11032025_091130.xml 0001685640-25-000006 7243
2025-11-03 3 xslF345X02/form3-11032025_091117.xml 0001685640-25-000004 8248
2025-11-03 8-K FORM 8-K 5.02 0001104659-25-105548 001-39130 251444197 34 193467 1 1
2025-10-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002032300-25-000002 005-91207 251395656 34 5424
2025-10-10 4 xslF345X05/form4-10102025_081040.xml 0002089250-25-000004 7227
2025-10-10 3 xslF345X02/form3-10102025_081001.xml 0002089250-25-000003 8234
2025-10-09 8-K FORM 8-K 5.02 0001104659-25-098354 001-39130 251385208 34 193794 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000529 005-91207 251217894 34 6700
2025-08-11 S-8 FORM S-8 0001104659-25-076232 333-289497 251202999 33 235126 1 1
2025-08-11 10-Q 10-Q 0001558370-25-011052 001-39130 251202211 34 6163288 1 1
2025-08-11 8-K FORM 8-K 2.02,7.01,9.01 0001104659-25-076153 001-39130 251202007 34 6543662 1 1
2025-08-05 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-013584 4839
2025-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010689 7046
2025-06-02 8-K FORM 8-K 5.02,7.01,9.01 0001104659-25-055248 001-39130 251013219 34 221994 1 1
2025-05-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010577 7194
2025-05-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010578 7325
2025-05-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010576 7226
2025-05-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010575 7189
2025-05-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010570 7188
2025-05-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-010569 7182
2025-05-30 8-K FORM 8-K 5.02,5.07 0001104659-25-054867 001-39130 251010855 34 218231 1 1
2025-05-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-079686 005-91207 251010724 34 16692
2025-05-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-079676 005-91207 251010645 34 16647
2025-05-08 10-Q 10-Q 0001558370-25-006994 001-39130 25926778 34 5542224 1 1
2025-05-08 8-K FORM 8-K 2.02,7.01,9.01 0001104659-25-046124 001-39130 25926342 34 4320748 1 1
2025-05-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-009168 005-91207 25923949 34 9327
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-045571 005-91207 25921965 34 11324
2025-04-17 ARS ARS 0001104659-25-036038 001-39130 25847683 34 2363622
2025-04-17 DEFA14A DEFA14A 0001104659-25-036024 001-39130 25847599 34 498160
2025-04-17 DEF 14A DEF 14A 0001104659-25-036020 001-39130 25847539 34 4990616 1 1
2025-04-07 PRE 14A PRE 14A 0001104659-25-032623 001-39130 25818171 34 5444005 1 1
2025-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-006864 4640
2025-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-006862 4672
2025-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-006859 4647
2025-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-006857 4660
2025-03-31 8-K FORM 8-K 8.01,9.01 0001104659-25-029612 001-39130 25788876 34 250704 1 1
2025-03-21 S-8 FORM S-8 0001104659-25-026691 333-286013 25761039 33 99701
2025-03-21 10-K 10-K 0001558370-25-003460 001-39130 25760472 34 10634308 1 1
2025-03-20 8-K FORM 8-K 2.02,7.01,9.01 0001104659-25-026142 001-39130 25756634 34 6675327 1 1
2025-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003499 8828
2025-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003498 11481
2025-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003497 10070
2025-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003496 10058
2025-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003495 7487
2025-02-21 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-003151 4940
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-014203 005-91207 25629786 34 11342
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000935836-25-000126 005-91207 25618506 34 18332
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-012142 005-91207 25614619 34 10125
2025-01-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-004405 005-91207 25578352 34 9234
2024-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-24-119171 005-91207 241463821 34 10679
2024-11-14 SC 13G/A tela13ga1.htm 0000935836-24-000692 005-91207 241459708 34 29824
2024-11-08 10-Q 10-Q 0001558370-24-015050 001-39130 241440507 34 5393428 1 1
2024-11-07 8-K FORM 8-K 2.02,7.01,9.01 0001104659-24-115317 001-39130 241435957 34 4473196 1 1
2024-10-29 SC 13G tela13g.htm 0000935836-24-000644 005-91207 241406648 34 61357
2024-10-28 SC 13G/A SC 13G/A 0001193125-24-245498 005-91207 241400920 34 86027
2024-10-25 SC 13D/A AMENDMENT NO. 6 0000947871-24-000823 005-91207 241397355 34 92436
2024-10-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-017930 4860
2024-10-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-017929 4688
2024-10-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-017928 4696
2024-10-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-017927 4707
2024-10-23 8-K FORM 8-K 1.01,9.01 0001104659-24-110891 001-39130 241390040 34 701607 1 1
2024-10-23 424B5 424B5 0001104659-24-110889 333-275511 241390017 33 714876
2024-10-22 424B5 424B5 0001104659-24-110558 333-275511 241386389 33 716384
2024-10-22 8-K FORM 8-K 2.02,7.01 0001104659-24-110552 001-39130 241386331 34 210137 1 1
2024-10-01 SC 13D/A AMENDMENT NO. 5 0000947871-24-000783 005-91207 241344572 34 97181
2024-08-13 10-Q 10-Q 0001558370-24-012060 001-39130 241201821 34 5248266 1 1
2024-08-12 8-K FORM 8-K 2.02,7.01,9.01 0001104659-24-088353 001-39130 241196999 34 3523628 1 1
2024-08-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-014524 4844
2024-07-30 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002032300-24-000001 005-91207 241159147 34 6500
2024-07-22 SC 13G tela13g.htm 0000935836-24-000490 005-91207 241131353 34 29813
2024-07-02 SC 13D/A AMENDMENT NO. 4 0000947871-24-000584 005-91207 241096633 34 91136
2024-07-02 4 xslF345X05/ownership.xml 0000947871-24-000583 11362
2024-06-28 144 xsl144X01/primary_doc.xml 0000947871-24-000581 001-39130 241087127 33 5417
2024-06-10 SC 13G/A AMENDMENT TO FORM SC 13G 0001839882-24-018369 005-91207 241031562 34 128202
2024-06-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012092 7198
2024-06-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012091 7230
2024-06-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012090 7186
2024-06-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012089 7192
2024-06-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012088 7329
2024-06-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012081 6929
2024-06-06 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-012080 5519
2024-06-06 8-K FORM 8-K 5.02,5.07,8.01,9.01 0001104659-24-069099 001-39130 241025254 34 243075 1 1
2024-05-20 8-K FORM 8-K 8.01,9.01 0001104659-24-063416 001-39130 24964662 34 231766 1 1
2024-05-10 10-Q 10-Q 0001558370-24-007784 001-39130 24934806 34 4553761 1 1
2024-05-09 8-K FORM 8-K 2.02,7.01,9.01 0001104659-24-059355 001-39130 24931029 34 4545767 1 1
2024-04-18 ARS ARS 0001104659-24-048842 001-39130 24854385 34 2268361
2024-04-18 DEFA14A DEFA14A 0001104659-24-048839 001-39130 24854367 34 515410
2024-04-18 DEF 14A DEF 14A 0001104659-24-048835 001-39130 24854347 34 1820496
2024-04-15 8-K FORM 8-K 8.01,9.01 0001104659-24-046970 001-39130 24843095 34 228557 1 1
2024-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-007843 4664
2024-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-007842 4654
2024-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-007841 4646
2024-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-007840 4679
2024-04-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-007839 4656
2024-03-22 S-8 FORM S-8 0001104659-24-037909 333-278183 24775835 33 99173
2024-03-22 10-K 10-K 0001558370-24-003782 001-39130 24775095 34 9497955 1 1
2024-03-21 8-K FORM 8-K 2.02,7.01,8.01,9.01 0001104659-24-037296 001-39130 24771554 34 4499504 1 1
2024-03-20 8-K FORM 8-K 8.01,9.01 0001104659-24-036394 001-39130 24766278 34 218750 1 1
2024-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004584 6083
2024-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004581 10068
2024-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004579 8826
2024-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004576 10055
2024-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004574 10332
2024-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004572 10071
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004239 6494
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004238 4844
2024-02-16 4 4 0000950170-24-016357 68525
2024-02-16 3/A 3/A 0000950170-24-016343 11320
2024-02-14 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001999371-24-002358 005-91207 24640702 34 70531
2024-02-14 SC 13G SC 13G 0001193125-24-034908 005-91207 24632075 34 141821
2024-02-07 SC 13G/A formsc13ga.htm 0001493152-24-005337 005-91207 24606302 34 92037
2023-12-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-022069 4340
2023-11-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-20 16:05:00 9999999995-23-003399 333-275511 231424377 33 1687
2023-11-16 CORRESP filename1.htm 0001104659-23-119092 6708
2023-11-16 UPLOAD filename1.pdf 0000000000-23-012565 40371
2023-11-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-020848 5065
2023-11-14 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-020847 4901
2023-11-13 S-3 S-3 0001104659-23-117290 333-275511 231399592 33 1362185
2023-11-13 10-Q 10-Q 0001558370-23-018822 001-39130 231398545 34 5911232 1 1
2023-11-09 8-K FORM 8-K 2.02,7.01,9.01 0001104659-23-116264 001-39130 231392277 34 3909135 1 1
2023-10-20 8-K FORM 8-K 1.01 0001104659-23-110478 001-39130 231337226 34 200486 1 1
2023-10-06 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-23-011983 005-91207 231313281 34 92263
2023-09-28 8-K FORM 8-K 5.02 0001104659-23-104741 001-39130 231289515 34 199291 1 1
2023-08-16 8-K FORM 8-K 8.01,9.01 0001104659-23-092205 001-39130 231176476 34 225399 1 1
2023-08-10 10-Q 10-Q 0001558370-23-014494 001-39130 231159256 34 5353087 1 1
2023-08-09 8-K FORM 8-K 2.02,7.01,9.01 0001104659-23-089299 001-39130 231155078 34 10521555 1 1
2023-08-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-015857 4642
2023-08-04 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-015856 9651
2023-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-012779 7223
2023-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-012778 7080
2023-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-012777 7092
2023-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-012776 7124
2023-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-012775 7118
2023-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-012774 7087
2023-06-02 8-K FORM 8-K 5.07 0001104659-23-067533 001-39130 23988640 34 205286 1 1
2023-05-11 10-Q 10-Q 0001558370-23-009426 001-39130 23912004 34 4589810 1 1
2023-05-11 8-K FORM 8-K 2.02,7.01,9.01 0001104659-23-059119 001-39130 23910926 34 8960822 1 1
2023-04-21 4 xslF345X04/ownership.xml 0000947871-23-000484 11222
2023-04-21 SC 13D/A AMENDMENT NO. 3 0000947871-23-000483 005-91207 23837114 34 92658
2023-04-20 8-K FORM 8-K 1.01,9.01 0001104659-23-047844 001-39130 23833763 34 611988 1 1
2023-04-20 424B5 424B5 0001104659-23-047745 333-251505 23833154 33 759961
2023-04-20 4 xslF345X04/ownership.xml 0001493152-23-013075 5239
2023-04-19 144 xsl144X01/primary_doc.xml 0000947871-23-000478 001-39130 23831117 33 4782
2023-04-18 8-K FORM 8-K 2.02 0001104659-23-046698 001-39130 23826817 34 207524 1 1
2023-04-18 424B5 424B5 0001104659-23-046694 333-251505 23826772 33 760885
2023-04-17 ARS ARS 0001104659-23-046181 001-39130 23824035 34 3264690
2023-04-17 DEFA14A DEFA14A 0001104659-23-046177 001-39130 23824022 34 486222
2023-04-17 DEF 14A DEF 14A 0001104659-23-046172 001-39130 23824001 34 3209810
2023-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008668 4550
2023-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008667 4575
2023-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008666 4552
2023-04-04 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008665 4541
2023-03-31 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-008208 6276
2023-03-23 S-8 FORM S-8 0001104659-23-036134 333-270803 23757108 33 88595
2023-03-23 10-K 10-K 0001558370-23-004468 001-39130 23756852 34 8411497 1 1
2023-03-23 8-K FORM 8-K 8.01,9.01 0001104659-23-035822 001-39130 23754457 34 239680 1 1
2023-03-21 8-K FORM 8-K 2.02,7.01,9.01 0001104659-23-035061 001-39130 23749816 34 4725018 1 1
2023-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-005028 8511
2023-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-005027 9929
2023-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-005026 9920
2023-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-005025 8525
2023-02-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-005024 5948
2023-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-004533 4627
2023-02-21 8-K FORM 8-K 8.01,9.01 0001104659-23-023518 001-39130 23645250 34 214841 1 1
2023-02-15 SC 13G/A formsc13ga.htm 0001493152-23-005128 005-91207 23633575 34 84844
2023-02-14 SC 13G/A TELA BIO, INC. 0000902664-23-001729 005-91207 23623875 34 63102
2023-01-10 8-K FORM 8-K 7.01,9.01 0001104659-23-002441 001-39130 23519678 34 4543313 1 1
2023-01-09 8-K FORM 8-K 8.01,9.01 0001104659-23-002053 001-39130 23516545 34 217119 1 1
2022-11-10 10-Q 10-Q 0001558370-22-017464 001-39130 221378329 34 5233823 1 1
2022-11-09 8-K FORM 8-K 2.02,7.01,9.01 0001104659-22-116468 001-39130 221372554 34 10433835 1 1
2022-11-04 4 xslF345X03/ownership.xml 0001493152-22-030666 7507
2022-10-26 8-K FORM 8-K 8.01,9.01 0001104659-22-111340 001-39130 221331088 34 220710 1 1
2022-10-11 4 xslF345X03/ownership.xml 0001493152-22-028176 7044
2022-09-26 4 xslF345X03/ownership.xml 0001493152-22-026798 7508
2022-09-19 4 xslF345X03/ownership.xml 0001493152-22-026276 7507
2022-09-16 4 xslF345X03/ownership.xml 0001493152-22-026144 10858
2022-09-15 4 xslF345X03/ownership.xml 0001493152-22-025979 7505
2022-08-24 SC 13G formsc13g.htm 0001493152-22-023880 005-91207 221188474 34 84455
2022-08-22 SC 13D/A SC 13D/A 0001193125-22-226407 005-91207 221183598 34 159718
2022-08-19 SC 13D/A AMENDMENT NO. 2 0000947871-22-000918 005-91207 221181010 34 90372
2022-08-19 4 FORM 4 SUBMISSION 0000899243-22-029273 12023
2022-08-17 8-K FORM 8-K 1.01,9.01 0001104659-22-092239 001-39130 221175198 34 587165 1 1
2022-08-17 424B5 424B5 0001104659-22-092236 333-251505 221175177 33 1057895
2022-08-16 4 xslF345X03/ownership.xml 0001493152-22-023186 7044
2022-08-15 424B5 424B5 0001104659-22-091215 333-251505 221165764 33 1060793
2022-08-15 8-K FORM 8-K 7.01,9.01 0001104659-22-090443 001-39130 221162208 34 3479741 1 1
2022-08-12 4/A xslF345X03/ownership.xml 0001493152-22-022214 7606
2022-08-12 4 xslF345X03/ownership.xml 0001493152-22-022193 7530
2022-08-11 10-Q 10-Q 0001558370-22-013286 001-39130 221155980 34 5189916 1 1
2022-08-10 8-K FORM 8-K 2.02,9.01 0001104659-22-088622 001-39130 221151809 34 291227 1 1
2022-08-02 4 xslF345X03/ownership.xml 0001493152-22-021074 7529
2022-07-22 4 xslF345X03/ownership.xml 0001493152-22-020185 7526
2022-07-21 4 xslF345X03/ownership.xml 0001493152-22-020067 7529
2022-07-20 4 xslF345X03/ownership.xml 0001493152-22-019956 7528
2022-07-18 SC 13D/A SC 13D/A 0001193125-22-196316 005-91207 221089395 34 163192
2022-07-13 4 FORM 4 SUBMISSION 0000899243-22-026036 15572
2022-07-08 4 FORM 4 SUBMISSION 0000899243-22-025833 15572
2022-07-05 4 FORM 4 SUBMISSION 0000899243-22-025125 15572
2022-07-05 4 xslF345X03/ownership.xml 0001493152-22-018583 5121
2022-06-30 4 xslF345X03/ownership.xml 0001493152-22-018273 8723
2022-06-29 4 FORM 4 SUBMISSION 0000899243-22-024535 15572
2022-06-24 4 xslF345X03/ownership.xml 0001493152-22-017768 7040
2022-06-24 4 FORM 4 SUBMISSION 0000899243-22-024087 15572
2022-06-23 SC 13G/A SC 13G/A 0001104659-22-073706 005-91207 221033545 34 74928
2022-06-23 4 OWNERSHIP DOCUMENT 0001104659-22-073703 7119
2022-06-22 4 xslF345X03/ownership.xml 0001493152-22-017529 7543
2022-06-21 4 FORM 4 SUBMISSION 0000899243-22-023457 15565
2022-06-15 4 FORM 4 SUBMISSION 0000899243-22-022665 15571
2022-06-10 4 xslF345X03/ownership.xml 0001493152-22-016481 7528
2022-06-10 4 FORM 4 SUBMISSION 0000899243-22-021988 15572
2022-06-10 SC 13D formsc13d.htm 0001493152-22-016439 005-91207 221008841 34 89872
2022-06-07 4 FORM 4 SUBMISSION 0000899243-22-021391 15572
2022-06-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014449 4854
2022-06-03 SC 13G formsc13g.htm 0001493152-22-015824 005-91207 22994303 34 90080
2022-06-02 4 FORM 4 SUBMISSION 0000899243-22-020802 15568
2022-06-02 8-K FORM 8-K 5.07 0001104659-22-067626 001-39130 22990991 34 205546 1 1
2022-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014133 7083
2022-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014131 7188
2022-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014130 7057
2022-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014128 7045
2022-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014127 7051
2022-06-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014126 7089
2022-06-01 SC 13D/A SC 13D/A 0001193125-22-164957 005-91207 22986763 34 166875
2022-05-31 8-K FORM 8-K 1.01,1.02,2.03,9.01 0001104659-22-066225 001-39130 22980432 34 1201161 1 1
2022-05-27 4 FORM 4 SUBMISSION 0000899243-22-019995 15568
2022-05-24 4 FORM 4 SUBMISSION 0000899243-22-019393 15568
2022-05-19 4 FORM 4 SUBMISSION 0000899243-22-018934 15568
2022-05-16 4 FORM 4 SUBMISSION 0000899243-22-018195 15568
2022-05-11 4 FORM 4 SUBMISSION 0000899243-22-017676 15568
2022-05-11 10-Q 10-Q 0001558370-22-008301 001-39130 22913290 34 4556031 1 1
2022-05-10 8-K FORM 8-K 2.02,7.01,9.01 0001104659-22-058223 001-39130 22909520 34 5881794 1 1
2022-05-09 4 FORM 4 SUBMISSION 0000899243-22-017284 13809
2022-05-04 4 FORM 4 SUBMISSION 0000899243-22-016664 15568
2022-04-29 4 FORM 4 SUBMISSION 0000899243-22-016040 15568
2022-04-27 4 FORM 4 SUBMISSION 0000899243-22-015733 13882
2022-04-21 DEFA14A DEFA14A 0001104659-22-048037 001-39130 22839599 34 3749719
2022-04-21 DEF 14A DEF 14A 0001104659-22-048036 001-39130 22839595 34 3501184
2022-04-19 4 FORM 4 SUBMISSION 0000899243-22-015076 15681
2022-04-04 4 FORM 4 SUBMISSION 0000899243-22-013262 13877
2022-04-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009235 4543
2022-04-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009232 4509
2022-04-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009228 4520
2022-04-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-009221 4518
2022-03-31 4 FORM 4 SUBMISSION 0000899243-22-012918 13883
2022-03-24 4 FORM 4 SUBMISSION 0000899243-22-012127 12040
2022-03-23 S-8 FORM S-8 0001104659-22-037080 333-263797 22763726 33 99683
2022-03-23 10-K 10-K 0001558370-22-004151 001-39130 22763339 34 8333568 1 1
2022-03-21 8-K FORM 8-K 2.02,7.01,9.01 0001104659-22-036114 001-39130 22755811 34 3884872 1 1
2022-03-16 4 FORM 4 SUBMISSION 0000899243-22-011303 15683
2022-03-03 8-K FORM 8-K 8.01,9.01 0001104659-22-029676 001-39130 22706717 34 214033 1 1
2022-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005916 4544
2022-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005914 4510
2022-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005912 4520
2022-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005910 4534
2022-02-28 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005907 4519
2022-02-28 SC 13D/A SC 13D/A 0001193125-22-057508 005-91207 22688175 34 167456
2022-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005780 6970
2022-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005779 6983
2022-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005778 6962
2022-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005777 6993
2022-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005776 6958
2022-02-25 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005775 6973
2022-02-24 4 FORM 4 SUBMISSION 0000899243-22-007737 15708
2022-02-18 4 FORM 4 SUBMISSION 0000899243-22-007089 15701
2022-02-16 4 FORM 4 SUBMISSION 0000899243-22-006640 13874
2022-02-14 4 FORM 4 SUBMISSION 0000899243-22-006233 13885
2022-02-14 SC 13G/A telabiov3.txt 0001590144-22-000015 005-91207 22634029 34 274206
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022683 005-91207 22631354 34 76793
2022-02-14 SC 13G/A TELA BIO, INC. 0000902664-22-001589 005-91207 22625523 34 60667
2022-02-10 4 FORM 4 SUBMISSION 0000899243-22-005630 13879
2022-02-01 4 FORM 4 SUBMISSION 0000899243-22-003797 13874
2022-01-28 4 FORM 4 SUBMISSION 0000899243-22-003575 13876
2022-01-26 4 FORM 4 SUBMISSION 0000899243-22-003247 13876
2022-01-19 SC 13D/A SC 13D/A 0001193125-22-012311 005-91207 22537839 34 164538
2022-01-19 4 FORM 4 SUBMISSION 0000899243-22-002300 12022
2022-01-14 4 FORM 4 SUBMISSION 0000899243-22-002019 12014
2022-01-12 4 FORM 4 SUBMISSION 0000899243-22-001780 13902
2022-01-07 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-000807 12493
2022-01-07 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-000806 5334
2022-01-04 4 FORM 4 SUBMISSION 0000899243-22-000689 12013
2022-01-04 8-K FORM 8-K 5.02 0001104659-22-000943 001-39130 22506498 34 199711 1 1
2021-12-22 4 FORM 4 SUBMISSION 0000899243-21-049415 12017
2021-12-17 4 FORM 4 SUBMISSION 0000899243-21-048822 13882
2021-12-14 4 FORM 4 SUBMISSION 0000899243-21-048156 13879
2021-12-08 4 FORM 4 SUBMISSION 0000899243-21-047397 15664
2021-12-03 4 PRIMARY DOCUMENT 0001879785-21-000024 4845
2021-12-01 4 OWNERSHIP DOCUMENT 0001104659-21-145591 9015
2021-11-23 4 FORM 4 SUBMISSION 0000899243-21-045832 13888
2021-11-19 4 FORM 4 SUBMISSION 0000899243-21-045426 13893
2021-11-12 4 FORM 4 SUBMISSION 0000899243-21-044468 12021
2021-11-12 10-Q 10-Q 0001558370-21-015754 001-39130 211402845 34 4501023 1 1
2021-11-10 8-K FORM 8-K 2.02,7.01,9.01 0001104659-21-136932 001-39130 211396590 34 4910276 1 1
2021-11-09 8-K FORM 8-K 8.01,9.01 0001104659-21-136019 001-39130 211389900 34 253221 1 1
2021-11-01 8-K FORM 8-K 8.01,9.01 0001104659-21-132339 001-39130 211367155 34 221989 1 1
2021-10-29 4 FORM 4 SUBMISSION 0000899243-21-042025 12025
2021-10-22 4 FORM 4 SUBMISSION 0000899243-21-041319 12023
2021-10-13 4 FORM 4 SUBMISSION 0000899243-21-040139 13733
2021-10-08 4 FORM 4 SUBMISSION 0000899243-21-039655 11969
2021-09-29 4 PRIMARY DOCUMENT 0001192482-21-000734 5262
2021-09-29 3 OWNERSHIP DOCUMENT 0001104659-21-120737 10067
2021-09-27 8-K FORM 8-K 5.02,9.01 0001104659-21-119817 001-39130 211282341 34 288124 1 1
2021-09-23 4 FORM 4 SUBMISSION 0000899243-21-037386 12018
2021-09-21 4 FORM 4 SUBMISSION 0000899243-21-036805 13866
2021-09-21 SC 13D/A SC 13D/A 0001193125-21-278455 005-91207 211267290 34 169366
2021-09-20 4/A FORM 4/A SUBMISSION 0000899243-21-036633 12427
2021-09-17 4 FORM 4 SUBMISSION 0000899243-21-036434 12018
2021-09-15 4 FORM 4 SUBMISSION 0000899243-21-036056 13849
2021-09-13 4 FORM 4 SUBMISSION 0000899243-21-035636 13888
2021-09-09 4 FORM 4 SUBMISSION 0000899243-21-035395 13731
2021-08-12 10-Q 10-Q 0001558370-21-011474 001-39130 211167525 34 4491219 1 1
2021-08-11 8-K FORM 8-K 2.02,7.01,9.01 0001104659-21-103464 001-39130 211163520 34 2045955 1 1
2021-06-21 SC 13G TelaBioInc_13G.txt 0001590144-21-000006 005-91207 211031485 34 212825
2021-06-16 4 FORM 4 SUBMISSION 0000899243-21-024092 12004
2021-06-09 4 FORM 4 SUBMISSION 0000899243-21-022886 12003
2021-06-07 4 FORM 4 SUBMISSION 0000899243-21-022289 11950
2021-06-07 8-K FORM 8-K 5.02,5.07 0001104659-21-077644 001-39130 21999547 34 32152
2021-06-04 4 PRIMARY DOCUMENT 0001192482-21-000493 5166
2021-06-04 4 PRIMARY DOCUMENT 0001192482-21-000492 8497
2021-06-04 4 PRIMARY DOCUMENT 0001192482-21-000491 5227
2021-06-04 4 PRIMARY DOCUMENT 0001192482-21-000490 8513
2021-06-04 4 PRIMARY DOCUMENT 0001192482-21-000489 5239
2021-06-04 4 PRIMARY DOCUMENT 0001192482-21-000488 8340
2021-06-04 3 PRIMARY DOCUMENT 0001192482-21-000487 6090
2021-05-27 4 FORM 4 SUBMISSION 0000899243-21-020839 13853

Latest XBRL company facts

One latest value per concept from companyfacts (281 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 45.19M 2026-11-05 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
dei EntityPublicFloat Entity Public Float USD 76.80M 2025-06-30 2025 FY 10-K 2026-03-25 0001104659-26-034507
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 706,187 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053117
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 995,641 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053117
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 889,039 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053117
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.97M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053117
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 10.26 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001104659-26-053117
ffd NetFeeAmt NetFeeAmt USD 5,137.96 2026-11-10 S-3 2026-11-10 0001104659-26-125285
ffd TtlFeeAmt TtlFeeAmt USD 5,137.96 2026-11-10 S-3 2026-11-10 0001104659-26-125285
ffd TtlOfferingAmt TtlOfferingAmt USD 150.00M 2026-11-10 S-3 2026-11-10 0001104659-26-125285
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-10 S-3 2026-11-10 0001104659-26-125285
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-10 S-3 2026-11-10 0001104659-26-125285
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 14.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.93M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.49M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 83,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 405.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 287,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 621,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 85,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 9.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap Assets Assets USD 49.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AssetsCurrent Assets, Current USD 44.60M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 4,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 15,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CapitalizedContractCostGross Capitalized Contract Cost, Gross USD 0 2021-09-30 2021 Q3 10-Q 2021-11-12 0001558370-21-015754
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 22.66M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -20.76M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001558370-21-015754
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 22.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -28.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 14.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 45.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 45.14M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CommonStockValue Common Stock, Value, Issued USD 45,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -32.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 8.05M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization USD 18.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CostOfGoodsAndServicesSoldAmortization Cost, Amortization USD 285,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 86,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 86,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 40.00M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001104659-25-112476
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 4.35M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DebtInstrumentUnamortizedPremium Debt Instrument, Unamortized Premium USD 2.00M 2024-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 1.73M 2019-09-30 2019 Q3 10-Q 2019-12-18 0001558370-19-011565
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 144,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 140,000 2024-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 147,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 609,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 1.62M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 86.13M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.04M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 295,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 609,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 75.49M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 224.70M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.59M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.16M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 252,000 2018-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 85.52M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap Depreciation Depreciation USD 512,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 7.58M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 31.49M 2021-12-31 2022 FY 10-K 2023-03-23 0001558370-23-004468
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.71 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001558370-21-015754
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.57 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.189 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.48 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 218,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0001558370-25-003460
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.004 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0001558370-25-003460
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 568,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 13,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001558370-21-015754
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 5.72M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 5,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 2.50M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 100,000 2023-12-31 2023 FY 10-K 2024-03-22 0001558370-24-003782
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 400,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 400,000 2023-12-31 2023 FY 10-K 2024-03-22 0001558370-24-003782
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 400,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 400,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 400,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 21,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -75,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD -100,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-21 0001558370-25-003460
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -18,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 2,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 2.16M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -888,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 11.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap GrossProfit Gross Profit USD 38.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -39.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -32.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 556,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.63 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001558370-20-006726
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 76,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 223,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 7.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -8.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 254,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 206,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 90,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -1.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 2.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -686,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -24,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap IncreaseInCarryingAmountOfRedeemablePreferredStock Increase in Carrying Amount of Redeemable Preferred Stock USD 7.78M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 4.00M 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap IntangibleAssetsNetIncludingGoodwill Intangible Assets, Net (Including Goodwill) USD 2.91M 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap InterestExpense Interest Expense USD 1.33M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-10 0001558370-24-007784
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 6.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 5.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap InterestPayableCurrent Interest Payable, Current USD 40,000 2020-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 10.90M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap InventoryNet Inventory, Net USD 11.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 118,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap InventoryWriteDown Inventory Write-down USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.56M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five USD 460,000 2022-03-31 2022 Q1 10-Q 2022-05-11 0001558370-22-008301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 250,000 2024-12-31 2024 FY 10-K 2025-03-21 0001558370-25-003460
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five USD 386,000 2022-03-31 2022 Q1 10-Q 2022-05-11 0001558370-22-008301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four USD 377,000 2022-03-31 2022 Q1 10-Q 2022-05-11 0001558370-22-008301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three USD 368,000 2022-03-31 2022 Q1 10-Q 2022-05-11 0001558370-22-008301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two USD 360,000 2022-03-31 2022 Q1 10-Q 2022-05-11 0001558370-22-008301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months USD 349,000 2022-03-31 2022 Q1 10-Q 2022-05-11 0001558370-22-008301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 557,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 250,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 595,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 583,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 570,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 90,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001558370-23-018822
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 554,000 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap Liabilities Liabilities USD 74.07M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 49.49M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap LiabilitiesCurrent Liabilities, Current USD 72.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap LongTermDebt Long-term Debt USD 41.38M 2025-06-30 2025 Q2 10-Q 2025-08-11 0001558370-25-011052
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 56.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 55.65M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -367,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -29.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -32.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -33.28M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -5.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001558370-24-003782
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OperatingExpenses Operating Expenses USD 65.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -27.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OperatingLeaseCost Operating Lease, Cost USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 400,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.00M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 532,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.50M 2024-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap OperatingLeasePayments Operating Lease, Payments USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.31M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 364,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 425,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD -4,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -8,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -4,000 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap OtherCostAndExpenseOperating Other Cost and Expense, Operating USD 2.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OtherIncome Other Income USD 158,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-15 0001558370-20-006726
us-gaap OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross USD 4.50M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 9,000 2020-03-31 2020 Q1 10-Q 2020-05-15 0001558370-20-006726
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.21M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 713,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 722,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 3.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 247,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 9.28M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 1.00M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-21 0001558370-25-003460
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 185,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PreferredStockAccretionOfRedemptionDiscount Preferred Stock, Accretion of Redemption Discount USD 7.78M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 44.72M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 46.34M 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-08 0001558370-24-015050
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 40.00M 2022-01-01 2022-12-31 2024 FY 10-K 2025-03-21 0001558370-25-003460
us-gaap ProceedsFromIssuanceOfRedeemablePreferredStock Proceeds from Issuance of Redeemable Preferred Stock USD 14.37M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 5.73M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 30.00M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans Proceeds from Repayment of Loans by Employee Stock Ownership Plans USD 38,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 9.29M 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-23 0001558370-23-004468
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 12,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -32.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 1.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 5.71M 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.88M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD -97,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 9.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 188,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 5.73M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 42.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 6.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 200,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -430.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 57.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 895,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 50.60M 2019-11-01 2019-11-30 2020 Q3 10-Q 2020-11-12 0001558370-20-013708
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 45.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap SeveranceCosts1 Severance Costs USD 2.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 295,650 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0001558370-23-009426
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.043 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 100,000 2023-12-31 2023 FY 10-K 2024-03-22 0001558370-24-003782
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 8.65 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0001558370-23-014494
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 650,977 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.01 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-12 0001558370-20-013708
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 29 2021-12-31 2023 FY 10-K 2024-03-22 0001558370-24-003782
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 267 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-23 0001558370-23-004468
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.20M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001558370-22-017464
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 4.13 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 345,881 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.24M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 4.31 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 29 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-22 0001558370-24-003782
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.88 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.64 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.81 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap ShortTermInvestments Short-term Investments USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001558370-21-003483
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -24.58M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.04 2019-10-28 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap StockIssued1 Stock Issued USD 1,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-22 0001558370-24-003782
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 25 2019-10-28 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 38,431 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 146.30M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 47,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 21,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 46.34M 2023-01-01 2023-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 1,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 226,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-14 0001104659-25-112476
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 849,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 124.15M 2018-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2019-12-31 2019 FY 10-K 2020-03-30 0001558370-20-003346
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 3.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 8.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-25 0001104659-26-034507
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 1.64M 2018-12-31 2021 FY 10-K 2022-03-23 0001558370-22-004151
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 57.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 14.46M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001558370-21-015754
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 57.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001104659-26-125190
us-gaap WorkersCompensationLiabilityCurrent Workers' Compensation Liability, Current USD 5.13M 2022-09-30 2022 Q3 10-Q 2022-11-10 0001558370-22-017464

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →